Free Trial
CVE:VIR

Viridium Pacific Group (VIR) Stock Price, News & Analysis

Viridium Pacific Group logo
C$0.38 +0.02 (+5.56%)
(As of 06/7/2019)

About Viridium Pacific Group Stock (CVE:VIR)

Key Stats

Today's Range
C$0.37
C$0.41
50-Day Range
C$0.38
C$0.38
52-Week Range
C$0.36
C$1.15
Volume
26,500 shs
Average Volume
92,632 shs
Market Capitalization
C$37.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Receive VIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viridium Pacific Group and its competitors with MarketBeat's FREE daily newsletter.

VIR Stock News Headlines

When it comes to NVDA… “acceleration cycles” are the key
Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.
Pacific American Holdings Acquires Promising Silver Project
Pacific Urban Investors acquires Cupertino apartments
See More Headlines

VIR Stock Analysis - Frequently Asked Questions

Viridium Pacific Group's stock was trading at C$0.38 on January 1st, 2024. Since then, VIR shares have increased by 0.0% and is now trading at C$0.38.
View the best growth stocks for 2024 here
.

Shares of VIR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viridium Pacific Group investors own include Baytex Energy (BTE), Allena Pharmaceuticals (ALNA), Abacus Health Products (ABAHF), Aurora Cannabis (ACBFF), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS) and Ardelyx (ARDX).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
580
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.09 million
Cash Flow
C$0.13 per share
Book Value
C$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
C$37.52 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:VIR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners